- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Unichem Laboratories held its 62nd Annual General Meeting, where all proposed resolutions were overwhelmingly approved by shareholders. Key approvals include the adoption of standalone and consolidated financial results for the year ended March 31, 2025, and the re-appointment of Dr. Prakash A. Mody as a director. Shareholders also approved related party transactions with its holding company, Ipca Laboratories, and its US subsidiary. Additionally, the appointment of Secretarial Auditors for five years and the ratification of Cost Auditors' remuneration of ₹0.06 Cr for FY2026 were passed. This ensures continued robust governance and smooth operational continuity for the company.